Related Experiment Video
Updated: Apr 28, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and
Rounak Nassirpour, Sachin Mathur, Mark M Gosink
1Drug Safety, Pfizer Worldwide Research and Development, 1 Burtt Rd, Andover, MA 01810, USA. laurence.o.whiteley@pfizer.com.
Background:
MicroRNAs (miRNAs) are small, non-coding RNAs that regulate protein levels post-transcriptionally. miRNAs play important regulatory roles in many cellular processes and have been implicated in several diseases. Recent studies have reported significant levels of miRNAs in a variety of body fluids, raising the possibility that miRNAs could serve as useful biomarkers. Next-generation sequencing (NGS) is increasingly employed in biomedical investigations. Although concordance between this platform and qRT-PCR based assays has been reported in high quality specimens, information is lacking on comparisons in biofluids especially urine. Here we describe the changes in miRNA expression patterns in a rodent model of renal tubular injury (gentamicin). Our aim is to compare RNA sequencing and qPCR based miRNA profiling in urine specimen from control and rats with confirmed tubular injury.
Results:
Our preliminary examination of the concordance between miRNA-seq and qRT-PCR in urine specimen suggests minimal agreement between platforms probably due to the differences in sensitivity. Our results suggest that although miRNA-seq has superior specificity, it may not detect low abundant miRNAs in urine samples. Specifically, miRNA-seq did not detect some sequences which were identified by qRT-PCR. On the other hand, the qRT-PCR analysis was not able to detect the miRNA isoforms, which made up the majority of miRNA changes detected by NGS.
Conclusions:
To our knowledge, this is the first time that miRNA profiling platforms including NGS have been compared in urine specimen. miRNAs identified by both platforms, let-7d, miR-203, and miR-320, may potentially serve as promising novel urinary biomarkers for drug induced renal tubular epithelial injury.
Insights
Comparing next-generation sequencing (NGS) and quantitative reverse transcription PCR (qRT-PCR) for microRNA (miRNA) profiling in rat urine revealed platform-specific strengths and weaknesses. While both methods identified potential urinary biomarkers for kidney injury, their concordance was limited, highlighting the need for careful platform selection in biomarker discovery.
Area of Science:
- Molecular Biology
- Biomarker Discovery
- Genomics
Background:
- MicroRNAs (miRNAs) are key post-transcriptional regulators implicated in disease.
- Urinary miRNAs show potential as non-invasive biomarkers.
- Comparison of miRNA profiling platforms in urine is limited.
Purpose of the Study:
- To compare microRNA sequencing (miRNA-seq) and quantitative reverse transcription PCR (qRT-PCR) for miRNA profiling in rat urine.
- To evaluate miRNA expression changes in a rodent model of drug-induced renal tubular injury.
Main Methods:
- Rodent model of gentamicin-induced renal tubular injury.
- Urine sample collection from control and injured rats.
- MicroRNA profiling using next-generation sequencing (NGS) and qRT-PCR.
Main Results:
- Limited concordance observed between miRNA-seq and qRT-PCR in urine samples, likely due to sensitivity differences.
- miRNA-seq demonstrated superior specificity but may miss low-abundance miRNAs.
- qRT-PCR detected low-abundance miRNAs but failed to identify miRNA isoforms identified by NGS.
Conclusions:
- This study is the first to compare miRNA profiling platforms, including NGS, in urine.
- let-7d, miR-203, and miR-320 were identified by both platforms as potential urinary biomarkers.
- These miRNAs may serve as novel biomarkers for drug-induced renal tubular epithelial injury.
More Related Videos
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017